Acuta Capital Partners, LLC Xenon Pharmaceuticals Inc. Transaction History

Acuta Capital Partners, LLC

$98.8 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $1.21 Million - $1.67 Million	47,500 Added 21.11%	272,500 $8.29 Million
Q4 2021 Feb 14, 2022	SELL	$15.6 - $35.4 $3 Million - $6.81 Million	-192,409 Reduced 46.1%	225,000 $7.03 Million
Q2 2021 Aug 16, 2021	BUY	$16.81 - $20.0 $82,520 - $98,180	4,909 Added 1.19%	417,409 $7.77 Million
Q1 2021 May 17, 2021	BUY	$13.65 - $21.31 $4.54 Million - $7.09 Million	332,500 Added 415.63%	412,500 $7.38 Million
Q4 2020 Feb 16, 2021	SELL	$9.49 - $16.04 $2.09 Million - $3.53 Million	-220,000 Reduced 73.33%	80,000 $1.23 Million
Q3 2020 Nov 16, 2020	SELL	$10.82 - $13.35 $2.35 Million - $2.9 Million	-217,500 Reduced 42.03%	300,000 $3.32 Million
Q2 2020 Aug 14, 2020	SELL	$10.21 - $14.9 $1.13 Million - $1.65 Million	-111,000 Reduced 17.66%	517,500 $6.49 Million
Q1 2020 May 15, 2020	SELL	$8.08 - $17.57 $2.34 Million - $5.08 Million	-289,000 Reduced 31.5%	628,500 $7.13 Million
Q4 2019 Feb 14, 2020	BUY	$8.11 - $14.65 $1.74 Million - $3.15 Million	215,000 Added 30.6%	917,500 $12 Million
Q3 2019 Nov 14, 2019	BUY	$8.74 - $10.51 $8,740 - $10,510	1,000 Added 0.14%	702,500 $6.33 Million
Q2 2019 Aug 14, 2019	BUY	$8.51 - $10.75 $1.27 Million - $1.6 Million	149,000 Added 26.97%	701,500 $6.92 Million
Q1 2019 May 14, 2019	BUY	$6.39 - $10.42 $95,850 - $156,300	15,000 Added 2.79%	552,500 $5.61 Million
Q4 2018 Feb 14, 2019	BUY	$5.61 - $12.62 $308,550 - $694,100	55,000 Added 11.4%	537,500 $3.39 Million
Q3 2018 Nov 07, 2018	BUY	$9.0 - $14.9 $292,500 - $484,250	32,500 Added 7.22%	482,500 $6.37 Million
Q2 2018 Aug 15, 2018	BUY	$4.8 - $9.2 $2.16 Million - $4.14 Million	450,000 New	450,000 $4.14 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

Avoro Capital Advisors LLC New York, NY

5.67M
Shares

$220 Million
3.36% of portfolio
Driehaus Capital Management LLC Chicago, IL

4.6M
Shares

$179 Million
1.77% of portfolio
Wellington Management Group LLP Boston, MA

3.84M
Shares

$150 Million
0.03% of portfolio
Braidwell LP Stamford, CT

2.71M
Shares

$105 Million
3.02% of portfolio
Commodore Capital LP New York, NY

2.7M
Shares

$105 Million
9.03% of portfolio

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Account